Intra-Cellular Therapies

New Form 4 for Intra-Cellular Therapies Inc.

Intra-Cellular Therapies sent this email to their subscribers on February 28, 2024.

February 27, 2024

A Form 4 has been filed with the United States Securities and Exchange Commission.

View this filing →

Or click here to view all filings.

Text-only version of this email

Intra-Cellular Therapies Inc. February 27, 2024A Form 4 has been filed with the United States Securities and Exchange Commission. View this filing → Or click here to view all filings.

Show all

The Latest Emails Sent By Intra-Cellular Therapies

Weekly Summary Alert for Intra-Cellular Therapies Inc.

Weekly Summary Alert for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

New Form 144 for Intra-Cellular Therapies Inc.

New Form 144 for Intra-Cellular Therapies Inc.

New Form 144 for Intra-Cellular Therapies Inc.

New Form 144 for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

More Emails, Deals & Coupons From Intra-Cellular Therapies

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

Weekly Summary Alert for Intra-Cellular Therapies Inc.

Weekly Summary Alert for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.

New Form 4 for Intra-Cellular Therapies Inc.

New Form 4 for Intra-Cellular Therapies Inc.

New Form 8-K for Intra-Cellular Therapies Inc.

New Form 8-K for Intra-Cellular Therapies Inc.

New Form 144 for Intra-Cellular Therapies Inc.

New Form 144 for Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes

New Form 424B5 for Intra-Cellular Therapies Inc.

New Form 424B5 for Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Stock Quote Notification for Intra-Cellular Therapies Inc.

Stock Quote Notification for Intra-Cellular Therapies Inc.